INJEKTIONSFORMULIERUNG
European patent · EP4023292 · In force
Register entry
- Publication number
- EP4023292
- Application number
- EP20859347
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jun 25, 2020
- Published
- Jul 6, 2022
- Granted
- Jul 1, 2026
- Protection ends at the latest
- Jun 24, 2040
- Next annual fee due
- Jun 30, 2027
- IPC classes
- A61P 21/00 (2006.01)A61K 9/08 (2006.01)A61J 1/00 (2023.01)A61J 1/05 (2006.01)A61K 31/724 (2006.01)A61M 5/00 (2006.01)B65B 55/18 (2006.01)B65B 55/19 (2006.01)B65D 81/26 (2006.01)A61J 1/14 (2023.01)A61K 9/00 (2006.01)B65B 31/04 (2006.01)B65B 55/14 (2006.01)
- Priority
- JP 2019158309 30.08.2019
- PCT application
- PCT/JP2020/025042 25.06.2020
- PCT publication
- WO2021/039084 04.03.2021
- Filing language
- Japanese
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 1, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 01.07.2026
Parties
Holder
Inventor
YOSHIKAWA, Hiroki
Ashigarakami-gun, Kanagawa 259-0151, JP
ITO, Hiroshi
Ashigarakami-gun, Kanagawa 259-0151, JP
YAMAMOTO, Satoshi
Ashigarakami-gun, Kanagawa 259-0151, JP
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.